AirCurveTM 10 CS PaceWaveTM Support

AirCurve 10 CS PaceWave

Documents

Reference

ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.